Literature DB >> 19672681

Trends in adult leukemia incidence and survival in Denmark, 1943-2003.

Lau Caspar Thygesen1, Ove Juul Nielsen, Christoffer Johansen.   

Abstract

The etiology of leukemia is largely unknown. Ecological data indicating trends in incidence and survival can provide information about changes in risk factors, can reflect underlying changes in diagnostic classification, and can measure therapeutic advances. From the records of the Danish Cancer Registry with registration starting from 1943, we calculated age-specific, period-specific, and age-standardized (world standard) incidence rates of chronic lymphoid leukemia (CLL), acute lymphoid leukemia (ALL), chronic myeloid leukemia (CML), and acute myeloid leukemia (AML) for persons above the age of 18. Kaplan-Meier survival curves and median survival times were calculated. Between 1943 and 2003, there were 26,036 cases of leukemia reported. The age-specific incidence rates of CLL, CML, and AML were higher for older men and women, while the incidence rates of ALL by age were more homogeneous. The age-standardized incidence rates during the study period increased for CLL and AML, increased less strongly for ALL, and decreased for CML in both men and women, although the incidence rates for women were almost always lower. Patients with CLL had the longest survival time in all age groups. The median survival time increased for all leukemia subtypes throughout the period of study most pronounced for CLL since 1950 and CML since 1990.

Entities:  

Mesh:

Year:  2009        PMID: 19672681     DOI: 10.1007/s10552-009-9417-9

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  13 in total

1.  Age disparity in the dissemination of imatinib for treating chronic myeloid leukemia.

Authors:  Charles L Wiggins; Linda C Harlan; Harold E Nelson; Jennifer L Stevens; Cheryl L Willman; Edward N Libby; Robert A Hromas
Journal:  Am J Med       Date:  2010-08       Impact factor: 4.965

2.  Systematic review and meta-analysis of glyphosate exposure and risk of lymphohematopoietic cancers.

Authors:  Ellen T Chang; Elizabeth Delzell
Journal:  J Environ Sci Health B       Date:  2016-03-25       Impact factor: 1.990

3.  Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007.

Authors:  Graça M Dores; Susan S Devesa; Rochelle E Curtis; Martha S Linet; Lindsay M Morton
Journal:  Blood       Date:  2011-11-15       Impact factor: 22.113

4.  Mapping incidence and mortality of leukemia and its subtypes in 21 world regions in last three decades and projections to 2030.

Authors:  Rajesh Sharma; Chinmay Jani
Journal:  Ann Hematol       Date:  2022-05-10       Impact factor: 3.673

5.  Are incidence rates of adult leukemia in the United States significantly associated with birth cohort?

Authors:  Philip S Rosenberg; Katherine L Wilson; William F Anderson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-10-12       Impact factor: 4.254

6.  Long-term results of total body irradiation in adults with acute lymphoblastic leukemia.

Authors:  Simone Marnitz; Alexander Zich; Peter Martus; Volker Budach; Ulrich Jahn; Oliver Neumann; Renate Arnold
Journal:  Strahlenther Onkol       Date:  2014-03-05       Impact factor: 3.621

7.  Changing trends of chronic myeloid leukemia in greater Mumbai, India over a period of 30 years.

Authors:  Rajesh P Dikshit; Rajini Nagrani; Balkrishna Yeole; Shravani Koyande; Shripad Banawali
Journal:  Indian J Med Paediatr Oncol       Date:  2011-04

8.  Incidence and mortality trends of leukemia and lymphoma in Croatia, 1988-2009.

Authors:  Ina Novak; Ozren Jaksić; Tomislav Kulis; Katarina Batinjan; Ariana Znaor
Journal:  Croat Med J       Date:  2012-04       Impact factor: 1.351

9.  National trends in incidence and survival of chronic lymphocytic leukemia in Norway for 1953-2012: a systematic analysis of population-based data.

Authors:  Andrea Lenartova; Tom Børge Johannesen; Geir Erland Tjønnfjord
Journal:  Cancer Med       Date:  2016-11-04       Impact factor: 4.452

10.  Accelerated phase chronic myeloid leukemia: evaluation of clinical criteria as predictors of survival, major cytogenetic response and progression to blast phase.

Authors:  Vanessa Fiorini Furtado; Gustavo Rengel Santos; Denise Siqueira de Carvalho; Pedro Vinícius Staziaki; Ricardo Pasquini; Vaneuza Araújo Moreira Funke
Journal:  Rev Bras Hematol Hemoter       Date:  2015-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.